Sort by
Method for Ranking the Relative Importance of Lazio Roadway Network
Brayan González-Hernández
,Davide Shingo Usami
,Luca Persia
Posted: 31 December 2025
From Golomb to Bateman-Horn
Huan Xiao
Posted: 31 December 2025
Novel Developments in Nano Fertilizer for Sustainable Crop Production to Promote Global Food Security
Ram Chandra Choudhary
,Pravin Kumar Singh
,Yogesh Chandra J. Parmar
,Arunachalam Lakshmanan
Posted: 31 December 2025
Cardio-Renal Syndrome: Review and New Perspectives
María Martín
,María Fernández
,Laura Pérez Bacigalupe
,José Rozado
Posted: 31 December 2025
Graph-Transformer Reconstruction Learning for Unsupervised Anomaly Detection in Dependency-Coupled Systems
Chong Zhang
,Chihui Shao
,Junjie Jiang
,Yinan Ni
,Xiaoxuan Sun
To address the practical challenges of diverse anomaly patterns, strongly coupled dependencies, and high labeling costs in large-scale complex infrastructures, this paper presents an unsupervised anomaly detection method that integrates graph neural networks with Transformer models. The approach learns normal system behavior and identifies deviations without relying on anomaly labels. Infrastructure components are abstracted as nodes in a dependency graph, where nodes are characterized by multiple source observability signals. A graph encoder aggregates neighborhood information to produce structure-enhanced node representations. Self-attention mechanisms are introduced along the temporal dimension to capture long-range dynamic dependencies. This design enables joint modeling of structural relations and temporal evolution. A reconstruction-based training strategy is adopted to constrain the learning of normal patterns. Reconstruction error is used to derive anomaly scores for detection. To ensure reproducibility and ease of deployment, complete specifications of data organization, training procedures, and key hyperparameter settings are provided. Comparative experiments on public benchmarks demonstrate overall advantages across multiple evaluation metrics and confirm the effectiveness of the proposed framework in representing anomaly propagation and temporal drift characteristics in complex systems.
To address the practical challenges of diverse anomaly patterns, strongly coupled dependencies, and high labeling costs in large-scale complex infrastructures, this paper presents an unsupervised anomaly detection method that integrates graph neural networks with Transformer models. The approach learns normal system behavior and identifies deviations without relying on anomaly labels. Infrastructure components are abstracted as nodes in a dependency graph, where nodes are characterized by multiple source observability signals. A graph encoder aggregates neighborhood information to produce structure-enhanced node representations. Self-attention mechanisms are introduced along the temporal dimension to capture long-range dynamic dependencies. This design enables joint modeling of structural relations and temporal evolution. A reconstruction-based training strategy is adopted to constrain the learning of normal patterns. Reconstruction error is used to derive anomaly scores for detection. To ensure reproducibility and ease of deployment, complete specifications of data organization, training procedures, and key hyperparameter settings are provided. Comparative experiments on public benchmarks demonstrate overall advantages across multiple evaluation metrics and confirm the effectiveness of the proposed framework in representing anomaly propagation and temporal drift characteristics in complex systems.
Posted: 31 December 2025
Decoding Leukemic Stem Cells in AML: From Identification to Targeted Eradication
Elisavet Apostolidou
,Vasileios Georgoulis
,Dimitrios Leonardos
,Leonidas Benetatos
,Eleni Kapsali
,Eleftheria Hatzimichael
Posted: 31 December 2025
A Low-Overhead Inter-Process Communication Library with Minimal Dependencies for Efficient Microservice Communication
Daisuke Sugisawa
Posted: 31 December 2025
Productivity Maximization and Human Productive Potential
Sidharta Chatterjee
This paper discusses the theory of productivity maximisation in relation to human productive potential. If productivity is considered as means to attain certain outcomes, it must have practical implications. Herein, human productive potential is considered as a neurocognitive concept having its significance felt in personal and professional frontier, for human beings are always in search to maximise their productivity by tapping untapped potential latent within. This paper addresses this issue, while at the same time, it examines of the role of cognitive constraints in constraining human potential, which has important implications for the individual and industrial frontiers. In this respect, we have also discussed, in brief, the concept of anti-productivity, its nature, and practical implications.
This paper discusses the theory of productivity maximisation in relation to human productive potential. If productivity is considered as means to attain certain outcomes, it must have practical implications. Herein, human productive potential is considered as a neurocognitive concept having its significance felt in personal and professional frontier, for human beings are always in search to maximise their productivity by tapping untapped potential latent within. This paper addresses this issue, while at the same time, it examines of the role of cognitive constraints in constraining human potential, which has important implications for the individual and industrial frontiers. In this respect, we have also discussed, in brief, the concept of anti-productivity, its nature, and practical implications.
Posted: 31 December 2025
Nuclear Remodeling in Quiescent Cells: Conserved Mechanisms from Yeasts to Mammals
Sigurd Braun
,Cornelia Kilchert
,Aydan Bulut-Karslioglu
,Myriam Ruault
,Angela Taddei
,Fatemeh Rabbani
,Dominika Włoch-Salamon
Posted: 31 December 2025
Effects of Phenolic Acids with Different Structures and Lauric Acid on the Digestive Properties and Physicochemical Characteristics of Breadfruit Starch
Jiapeng Tian
,Xuan Zhang
,Wendi Zhang
,Kexue Zhu
,Xiaoai Chen
,Yutong Zhang
,Zuohua Xie
,Lixiang Zhou
,Yanru Zhou
,Yanjun Zhang
+1 authors
Posted: 31 December 2025
Uniform Models of Neutron and Quark (Strange) Stars in General Relativity
Genanady S. Bisnovatyi-Kogan
,E. A. Patraman
Posted: 31 December 2025
Gender Differences in the Incidence of Hereditary Gastric Cancer
Takuma Hayashi
,Ikuo Konisih
Gastric cancer (GC0 is primarily caused by Helicobacter pylori infection and smoking, with a higher incidence in families with multiple GC cases owing to lifestyle and genetic factors. The use of medications to eradicate H. pylori can reduce the incidence of GC. Furthermore, GC is the fourth most common cancer, affecting one in 11 men (9.1%) and one in 23 women (4.38%). The incidence of GC increases after 50 years of age, particularly among men. However, the reason for difference in incidence rates between both sexes remains unclear. We investigated the incidence of GC in families with hereditary breast and ovarian cancer (HBOC). The results showed that the incidence of GC in families with HBOC was 4.2 times higher than that in other families. Furthermore, the incidence of gastric cancer in families with HBOC and other families was 74.57% and 53.67% in men, respectively. Overall, the higher incidence of gastric cancer in men than that in women may be due to the underlying cause of hereditary GC.
Gastric cancer (GC0 is primarily caused by Helicobacter pylori infection and smoking, with a higher incidence in families with multiple GC cases owing to lifestyle and genetic factors. The use of medications to eradicate H. pylori can reduce the incidence of GC. Furthermore, GC is the fourth most common cancer, affecting one in 11 men (9.1%) and one in 23 women (4.38%). The incidence of GC increases after 50 years of age, particularly among men. However, the reason for difference in incidence rates between both sexes remains unclear. We investigated the incidence of GC in families with hereditary breast and ovarian cancer (HBOC). The results showed that the incidence of GC in families with HBOC was 4.2 times higher than that in other families. Furthermore, the incidence of gastric cancer in families with HBOC and other families was 74.57% and 53.67% in men, respectively. Overall, the higher incidence of gastric cancer in men than that in women may be due to the underlying cause of hereditary GC.
Posted: 31 December 2025
Numerical Investigation of the Effect of Straight Development Length on the Anchorage Performance of 180-Degree Rebar Hooks
Navoda Abeygunawardana
,Hikaru Nakamura
,Tatsuya Nakashima
,Taito Miura
Posted: 31 December 2025
Relationship Between Humphrey Automated Perimetry and Virtual Reality–Based Perimetry: A Constant dB Offset and Normative Data
Juan E Cedrún-Sánchez
,Ricardo Bernárdez-Vilaboa
,Laura Sánchez-Alamillos
,Marina Medina-Galdeano
,Carla Otero-Curras
,F. Javier Povedano-Montero
Posted: 31 December 2025
Hybrid Taint-Guided Kernel Fuzzing with Selective State Propagation
Arjun Mehta
,Rohan Srinivasan
,Neha Kapoor
Posted: 31 December 2025
A Biophysical Framework for Neurodegeneration: Prioritizing Protein Homeostasis Over Aggregate Toxicity
Jamir Pitton Rissardo
,Ana Leticia Fornari Caprara
Neurodegenerative research has long hypothesized that aggregated proteins such as amyloid‑β (Aβ), tau, and α‑synuclein (αSyn) are intrinsically toxic and are directly associated with the etiologies of Alzheimer’s disease (AD) and Parkinson’s disease (PD). However, emerging scientific evidence challenges this view. Plasma p‑tau217 shows weak correlation with cognitive severity, αSyn seed amplification assays provide only binary diagnostic support, and anti‑amyloid monoclonal antibodies yield modest short-term benefit while increasing amyloid-related imaging abnormality (ARIA) risk. Postmortem pathology and fluid biomarkers explain only a limited amount of variance in clinical outcomes, undermining their role as surrogate endpoints. We propose a biophysical framework in which aggregation reflects a supersaturation-driven phase transition that signals depletion of soluble, functional monomers rather than the emergence of toxic species. Within this paradigm, amyloid plaques, neurofibrillary tangles, and Lewy bodies represent tombstones of lost protein function, and neurodegeneration occurs when monomer supply falls below neuronal demand. This shift has practical implications for biomarker interpretation, staging, and therapeutic design. Future directions include quantifying monomer flux using stable-isotope labeling kinetics (SILK), integrating supply and demand ratios, and prioritizing mechanism-testing trials that restore protein homeostasis rather than indiscriminately clear aggregates. By reframing pathology as a marker of stress rather than a maker of disease, this approach may enable more effective precision therapeutics based on human biology.
Neurodegenerative research has long hypothesized that aggregated proteins such as amyloid‑β (Aβ), tau, and α‑synuclein (αSyn) are intrinsically toxic and are directly associated with the etiologies of Alzheimer’s disease (AD) and Parkinson’s disease (PD). However, emerging scientific evidence challenges this view. Plasma p‑tau217 shows weak correlation with cognitive severity, αSyn seed amplification assays provide only binary diagnostic support, and anti‑amyloid monoclonal antibodies yield modest short-term benefit while increasing amyloid-related imaging abnormality (ARIA) risk. Postmortem pathology and fluid biomarkers explain only a limited amount of variance in clinical outcomes, undermining their role as surrogate endpoints. We propose a biophysical framework in which aggregation reflects a supersaturation-driven phase transition that signals depletion of soluble, functional monomers rather than the emergence of toxic species. Within this paradigm, amyloid plaques, neurofibrillary tangles, and Lewy bodies represent tombstones of lost protein function, and neurodegeneration occurs when monomer supply falls below neuronal demand. This shift has practical implications for biomarker interpretation, staging, and therapeutic design. Future directions include quantifying monomer flux using stable-isotope labeling kinetics (SILK), integrating supply and demand ratios, and prioritizing mechanism-testing trials that restore protein homeostasis rather than indiscriminately clear aggregates. By reframing pathology as a marker of stress rather than a maker of disease, this approach may enable more effective precision therapeutics based on human biology.
Posted: 31 December 2025
Renoprotection by 5-Methoxytryptophan in Kidney Disease
Jonah P. Gutierrez
,Tram N. Diep
,Shaona Niu
,Liang-Jun Yan
Kidney disease, be it acute or chronic, has a complex pathology and is a significant human health problem. Increasing interest has been focused on exploring therapeutic targets that can be used to safeguard kidney function under a variety of detrimental conditions. In this article, we review the protective effects of 5-methoxytryptophan (5-MTP), a tryptophan metabolite, on kidney injury. Published studies indicate that serum 5-MTP is increased in patients with chronic kidney disease (CKD), suggesting that 5-MTP is a biomarker for CKD and has therapeutic values. Indeed, rodent models of kidney injury induced by folic acid, lipopolysaccharide (LPS), unilateral ureteral obstruction (UUO), and ischemia/reperfusion all demonstrate that exogenous 5-MTP exhibits nephroprotective effects. The underlying mechanisms involve anti-oxidative damage via activating antioxidant systems such as Nrf2/heme oxygenase-1, anti-inflammation, anti-fibrosis, and enhanced mitophagy. To further explore the underlying mechanisms and the potential of 5-MTP as a kidney therapeutic compound, future studies need to include more rodent models of kidney injury induced by a variety of insults. Moreover, how to boost endogenous 5-MTP content and its potential synergistic effects with other therapeutic approaches aiming to combat kidney diseases also remain to be explored.
Kidney disease, be it acute or chronic, has a complex pathology and is a significant human health problem. Increasing interest has been focused on exploring therapeutic targets that can be used to safeguard kidney function under a variety of detrimental conditions. In this article, we review the protective effects of 5-methoxytryptophan (5-MTP), a tryptophan metabolite, on kidney injury. Published studies indicate that serum 5-MTP is increased in patients with chronic kidney disease (CKD), suggesting that 5-MTP is a biomarker for CKD and has therapeutic values. Indeed, rodent models of kidney injury induced by folic acid, lipopolysaccharide (LPS), unilateral ureteral obstruction (UUO), and ischemia/reperfusion all demonstrate that exogenous 5-MTP exhibits nephroprotective effects. The underlying mechanisms involve anti-oxidative damage via activating antioxidant systems such as Nrf2/heme oxygenase-1, anti-inflammation, anti-fibrosis, and enhanced mitophagy. To further explore the underlying mechanisms and the potential of 5-MTP as a kidney therapeutic compound, future studies need to include more rodent models of kidney injury induced by a variety of insults. Moreover, how to boost endogenous 5-MTP content and its potential synergistic effects with other therapeutic approaches aiming to combat kidney diseases also remain to be explored.
Posted: 31 December 2025
Effects of Surface Treatment Methods and Staining Solutions on the Color Stability and Surface Roughness of CAD/CAM Hybrid Ceramic Materials
İrem Köklü Dağdeviren
,Umut Dağdeviren
,Turan Korkmaz
Posted: 31 December 2025
Process-Microstructure-Property Characteristics of Aluminum Walls Fabricated by Hybrid Wire Arc Additive Manufacturing with Friction Stir Processing
Ahmed Nabil Elalem
,Xin Wu
Posted: 31 December 2025
Making Mealtime Easier: Nutrition and Texture in Foods for the Elderly with Swallowing Difficulties in Formal and Informal Care
Cristina M. M. Almeida
,Juliana Beltrame
,Joana Marto
,Lídia Pinheiro
Posted: 31 December 2025
of 5,402